Evolution of subclinical hypothyroidism and its relation with glucose and triglycerides levels in morbidly obese patients after undergoing sleeve gastrectomy as bariatric procedure

Obesity Surgery

Volumn 24, Issue 5, 2014, Pages 791-795

  Ruiz Tovar, Jaime ^a,b   Boix, Evangelina ^a   Galindo, Isabel ^a   Zubiaga, Lorea ^a   Diez, María ^a   Arroyo, Antonio ^a   Calpena, Rafael ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^b NONE   (Spain)

Author keywords

Lipid profile; Sleeve gastrectomy; TSH

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LAPAROSCOPIC SLEEVE GASTRECTOMY; LAPAROSCOPIC SURGERY; LIPID ANALYSIS; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; POSITIVE END EXPIRATORY PRESSURE; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; SLEEVE GASTRECTOMY; SUBCLINICAL HYPOTHYROIDISM; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; WEIGHT REDUCTION; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; GASTRECTOMY; HYPOTHYROIDISM; METABOLISM; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RISK FACTOR;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES; WEIGHT LOSS;

EID: 84898053021     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-1150-5     Document Type: Article

References (22)

1. Tuzcu A, Bahceci M, Gokalp D, et al. Subclinical hypothyroidism may be associated with elevated high-sensitive C-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocrine J. 2005;52:89-94.
2. Vanderpump M. Subclinical hypothyroidism: the case against treatment. Trends Endocrinol Metab. 2003;14:262-6.
3. Diaz-Olmos R, Nogueira AC, Penalva DQF, et al. Frequency of subclinical thyroid dysfunction and risk factors for cardiovascular disease among women at a workplace. Sao Paulo Med J. 2010;128:18-23.
4. De Pergola G, Ciampolillo A, Paolotti S, et al. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrino (Oxf). 2007;67:265-9.
5. Biondi B, Palmieri EA, Lombardi G, et al. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002;137:904-14.
6. Gaziano JM, Hennekens CH, O'Donnell CJ, et al. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96:2520-5.
7. Mehta S, Mathur D, Chaturvedi M, et al. Thyroid hormone profile in obese subjects - a clinical study. J Indian Med Assoc. 2001;99:260-72.
8. Roelfsema F, Veldhuis JD. Thyrotropin secretion patterns in health and disease. Endocrine Rev 2013. doi: 10.1210/er.2012-1076.
9. Nyrnes A, Jorde R, Sundsfjord J. Serum TSH is positively associated with BMI. Int J Obes (Lond). 2006;30:100-5.
10. Fox CS, Pencina MJ, D'Agostino RB, et al. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med. 2008;168:587-92.
11. Chikunguwo S, Brethauer S, Nirujogi V, et al. Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis. 2007;3:631-5.
12. Marzullo P, Minocci A, Tagliaferri MA, et al. Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal and weight-related determinants. J Clin Endocrinol Metab. 2010;95:3965-72.
13. Rotondi M, Leporati P, Rizza MI, et al. Raised serum TSH in morbid-obese and non-obese patients: effect of the circulating lipid profile. Endocrine 2013. doi: 10.1007/S12020-013-9928-8.
14. Frias Lopez MC, Tárraga Lopez PJ, Rodriguez Montes JA, et al. Hipotiroidismo subclínico y factores de riesgo cardiovascular. Nutr Hosp. 2011;26:1355-62.
15. Velkoska Nakova V, Krstevska B, Bosevski M, et al. Dyslipidemia and hypertension in patients with hypothyroidism. Prilozi. 2009;30:93-102.
16. Vierhapper H, Nardi A, Grosser P. Prevalence of paradoxically normal serum cholesterol in morbidly obese women. Metabolism. 2000;49:607-10.
17. Ruiz-Tovar J, Oller I, Tomas A, et al. Midterm impact of sleeve gastrectomy, calibrated with a 50-Fr bougie, on weight loss, glucose hemostasis, lipid profiles and comorbidities in morbidly obese patients. Am Surg. 2012;78:969-74.
18. Galofre JC, Pujante P, Abreu C, et al. Relationship between thyroid-stimulating hormone and insulin in euthyroid obese men. Ann Nutr Metab. 2008;53:188-94.
19. Kouidhi S, Berhouma R, Ammar M, et al. Relationship of thyroid function with obesity and type 2 diabetes in euthyroid Tunisian subjects. Endocr Res. 2013;38:15-23.
20. Celik C, Abali R, Tasdemir N, et al. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome? Gynecol Endocrinol. 2012;28:615-8.
21. Proces S, Delgrange E, Vander Borght TV, et al. Minor alterations in thyroid-function tests associated with diabetes mellitus and obesity in outpatients without known thyroid illness. Acta Clin Belg. 2001;56:86-90.
22. Velija-Asimi Z, Karamehic J. The effects of treatment of subclinical hypothyroidism on metabolic control and hyperinsulinemia. Med Arh. 2007;61:20-1.